Background Evidence has recently been found for significant associations between genetic variation within the scavenger receptor class B type I gene (SR-BI), plasma lipids and anthropometric measurements in healthy Caucasians. The present case-control study was conducted to determine whether there is an association between three polymorphisms identified by the restriction endonucleases HaeIII, AluI and ApaI of SR-BI and coronary artery disease (CAD) in Korean subjects.
Introduction
HDL particles play an important role in reverse cholesterol transport (RCT), bringing excess cholesterol from peripheral tissues to the liver. This function of HDL is believed to contribute to its anti-atherogenic role. Thus, genetically caused abnormalities in any of the proteins regulating HDL metabolism may potentially impair RCT or the other cardioprotective properties attributed to HDL, leading to accelerated atherothrombosis.
It has been reported that hamster scavenger receptor class B type I (SR-BI) has the ability to mediate the binding of both modi¢ed and native LDL and also of anionic phospholipid s. 1 It has also been shown that murine SR-BI binds HDL, and mediates lipid transfer from HDL to cells without degradation of the apolipoproteins. SR-BI is dominantly expressed in the liver and non-placental steroidogenic tissues such as ovary, adrenal gland and testis. 2 Its tissue-speci¢c expression has also been con¢rmed in humans, 3, 4 and human SR-BI has been identi¢ed as a multilipoprotein receptor that binds HDL, LDL and VLDL. 3, 5 The human SR-BI gene (SR-BI) has been mapped to chromosome 1q24 and codes for a product of 409 amino acids. 4, 6 Recent reports have suggested signi¢cant sex-speci¢c associations between genetic variations of SR-BI, plasma lipids and anthropometric measurements in healthy Caucasians. 7 Coronary artery disease (CAD) is a multifactorial disorder, in which genetic and environmental factors, including defects in lipoprotein metabolism, play a major role. In view of the importance of SR-BI as a multilipoprotein receptor in lipoprotein metabolism, we investigated possible associations between genetic variations at three polymorphic sites in SR-BI (identi-¢ed by the restriction enzymes HaeIII, AluI and ApaI) and plasma lipid concentrations in Korean patients with CAD.
Materials and methods

Study subjects
The study subjects were recruited from the Seoul province of Korea. We selected 137 patients with angiographically con¢rmed CAD (86 men and 51 women) following recent myocardial infarction or angina. All cases had at least one coronary artery with more than 50% luminal obstruction. None were undergoing lipid-lowering therapy at the time of sampling. Diagnosis of myocardial infarction was based upon echocardiographic ¢ndings or measurements of serum cardiac markers. Blood samples were obtained 2 months after myocardial infarction. Patients with hypertension, diabetes and endocrine or metabolic disorders were excluded. The control group consisted of 124 individuals (67 men and 57 women) who were randomly selected following health screening to exclude those with a history of chest pain, diabetes, hypertension and general illness. The clinical details of the cases and controls are summarized in Table 1 .
DNA analysis
Total genomic DNA was prepared from whole blood after lysis of red blood cells. 8 The areas spanning each of the three polymorphic sites of SR-BI were ampli¢ed by polymerase chain reaction from genomic DNA using primers and reaction conditions described previously. 7 The polymorphisms were identi¢ed following digestion of ampli¢ed DNAwith one or other of the endonucleases HaeIII, AluI and ApaI. Alleles of each polymorphic site were classi¢ed as (+) or (7) depending on the presence or absence of a restriction enzyme cutting site.
Estimation of lipid concentrations
Whole blood was collected into potassium EDTA from individuals after an overnight fast and the plasma separated by centrifugation. Plasma cholesterol and triglyceride concentrations were measured enzymatically using commercial kits (Boehringer Mannheim, Germany) on an Hitachi 747 automatic chemistry analyser. HDL-cholesterol was determined, after precipitation of non-HDL lipoproteins with MgCl 2 and dextran sulphate, using a Gilford Impact 400E automatic analyser with reagents and calibrators from Boehringer Mannheim, Germany. LDL-cholesterol concentrations were calculated using the formula of Friedwald et al. 9 Apolipoproteins (apo) AI and B were measured by immunonephelometry (Behring Nephelometer, Behringwerke AG, Germany). Lipoprotein(a) concentrations were measured using a commercially available enzyme-linked immunosorbent assay kit (IMMUNO GMBH, Germany).
Data analysis
All statistical analyses were performed using the Statistical Analysis System software (SAS Institute Inc). The distribution of genotypes was tested for Hardy^Weinberg equilibrium, and for selection against a particular genotype, using w 2 analysis. Di¡erences between genotype allele numbers in each group were also compared using w 2 analysis. One-way analysis of variance (ANOVA) was performed to compare the lipid concentrations among di¡erent genotypes. Spearman's rank correlation was performed to assess the correlation between body mass index (BMI) and lipid concentrations. Statistical signi¢cance was accepted at the Pˆ0 ¢05 level. 
Results
As shown in Table 1 , the CAD group had a signi¢cantly higher BMI and plasma triglyceride concentrations, and lower HDL-cholesterol and apo AI concentrations, than the controls. The genotype distribution for each polymorphic locus did not deviate signi¢cantly from HardyŴ einberg equilibrium. No rare allele was identi¢ed for either the ApaI or the AluI polymorphic site. The comparison of allele frequencies and values of heterozygosity and polymorphism information content for the HaeIII polymorphism of SR-BI between cases and controls are shown in Table 2 . The frequency of a rare (7) allele at the HaeIII polymorphic site was signi¢cantly lower in the CAD cases than in the controls (Pˆ0¢001).
We examined whether the HaeIII polymorphism of SR-BI was associated with BMI and plasma lipid concentrations in Koreans. In the CAD group, the common allele was associated with a lower concentration [expressed as mean (standard deviation)] of HDL-cholesterol [7/7 genotype,1¢55 (0¢12) mmol/ L; +/7 genotype, 1¢10 (0¢31) mmol/ L; +/+ genotype, 1¢10 (0¢31) mmol/ L, Pˆ0 ¢02] and of apo AI [7/7 genotype, 1¢42 (0¢14) g/L; +/7 genotype, 1¢10 (0¢28) g/L; +/+ genotype, 1¢12 ( 0¢36) g/L, Pˆ0 ¢05]. When strati¢ed by sex, the association of the common allele and low HDL-cholesterol concentration remained only statistically signi¢cant in women with CAD [+/+ genotype (nˆ29), 1¢10 (0¢31) mmol/ L; +/7 genotype (nˆ19), 1¢16 (0¢31) mmol/ L; 7/7 genotype (nˆ3), 1¢61 (0¢05) mmol/ L, Pˆ0 ¢03]. In contrast, associations between apo AI and genotype were not a¡ected when strati¢ed by sex. The common allele was also associated with lower BMI in female controls [+/+ genotype (nˆ29), 23¢41 (2¢89) kg/m 2 ; +/7 genotype (nˆ19), 23¢42 (2¢05) kg/m 2 ; 7/7 genotype (nˆ3), 25¢88 (2¢12) kg/m 2 , Pˆ0 ¢02].
Discussion
A number of epidemiological studies have shown that, in addition to environmental factors, genetic mechanisms may play a role in determining susceptibility to atherosclerosis. In particular, defects in the genes that control lipid transport and metabolism have been shown to cause CAD. The potential role of SR-BI in the regulation of lipoprotein metabolism has attracted considerable interest. We therefore studied the relationship between genetic variation in this gene and CAD in Korean subjects in a case^control study.
In the present study, we have shown that the common (+) allele of the HaeIII polymorphism was signi¢cantly over-represented in CAD patients compared with controls. Concentrations of plasma HDL-cholesterol and apo AI also varied signi¢cantly according to HaeIII genotype in the CAD patients. However, the mutation causing the HaeIII polymorphism occurs in the third base at codon 350 in exon 8 and does not a¡ect the amino acid sequence of the protein. It is therefore possible that the observed associations might be a consequence of linkage disequilibrium between the HaeIII polymorphis m and an unknown allele of SR-BI or nearby genes that predisposes to atherosclerosis. In the present study, no rare alleles of the AluI and ApaI polymorphisms were iden-ti¢ed. This is in contrast to previous studies in which the rare allele frequencies were shown to be 0¢12 and 0¢10 in healthy Caucasians. 7 A possible explanation for this di¡erence could be di¡erences between Korean and white populations, genetic drift or selection against a particular allele.
Our results show that the common allele of the HaeIII polymorphism was associated with a lower BMI in female controls compared with the rare allele. This ¢nding is di¤cult to explain and may be due to genetic, environmental or other factors. BMI showed a negative correlation with both HDL (rˆ70¢2403, Pˆ0 ¢0072) and apo AI (rˆ70¢2752, Pˆ0 ¢002) concentrations. These ¢ndings support the thesis that BMI and the HaeIII polymorphism in£uence lipid levels by di¡erent mechanisms in female controls.
In conclusion, the HaeIII polymorphism of SR-BI, at least in Koreans, appears to show an association with HDL concentration in patients with CAD. In light of di¡erences in lipoprotein metabolism between humans and animals, further work is needed to examine the e¡ects of mutations in SR-BI. Disease association studies involving genetic variation in SR-BI has only been performed on healthy Caucasians. Further population and/or case^control studies of SR-BI polymorphism in other racial or ethnic groups are therefore required.
